DK1480953T3 - Fremgangsmåde til fremstilling af aripiprazol - Google Patents
Fremgangsmåde til fremstilling af aripiprazolInfo
- Publication number
- DK1480953T3 DK1480953T3 DK03780889T DK03780889T DK1480953T3 DK 1480953 T3 DK1480953 T3 DK 1480953T3 DK 03780889 T DK03780889 T DK 03780889T DK 03780889 T DK03780889 T DK 03780889T DK 1480953 T3 DK1480953 T3 DK 1480953T3
- Authority
- DK
- Denmark
- Prior art keywords
- aripiprazole
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003002996 | 2003-01-09 | ||
| PCT/JP2003/016256 WO2004063162A1 (en) | 2003-01-09 | 2003-12-18 | Process for preparing aripiprazole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK1480953T3 true DK1480953T3 (da) | 2005-12-19 |
| DK1480953T4 DK1480953T4 (da) | 2010-11-15 |
Family
ID=32652780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03780889.6T DK1480953T4 (da) | 2003-01-09 | 2003-12-18 | Fremgangsmåde til fremstilling af aripiprazol |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6995264B2 (da) |
| EP (1) | EP1480953B2 (da) |
| JP (2) | JP5797090B2 (da) |
| KR (1) | KR100583667B1 (da) |
| CN (1) | CN1263742C (da) |
| AR (1) | AR042702A1 (da) |
| AT (1) | ATE308524T1 (da) |
| AU (1) | AU2003288755C1 (da) |
| BR (2) | BRPI0305500B1 (da) |
| CA (2) | CA2458929C (da) |
| DE (1) | DE60302139T3 (da) |
| DK (1) | DK1480953T4 (da) |
| EG (1) | EG23557A (da) |
| ES (1) | ES2250919T5 (da) |
| HK (1) | HK1073110A1 (da) |
| MX (1) | MXPA04002519A (da) |
| MY (1) | MY129831A (da) |
| SI (1) | SI1480953T2 (da) |
| TW (1) | TWI258470B (da) |
| WO (1) | WO2004063162A1 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7714129B2 (en) * | 2003-12-16 | 2010-05-11 | Teva Pharmaceutical Industries Ltd. | Methods of preparing anhydrous aripiprazole form II |
| PT1613598E (pt) * | 2003-12-16 | 2012-01-13 | Teva Pharma | Métodos para preparar formas cristalinas de aripiprazol |
| WO2005077904A1 (en) * | 2004-02-05 | 2005-08-25 | Teva Pharmaceutical Industries, Ltd. | Process for preparing aripiprazole |
| US7507823B2 (en) | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
| US7872132B2 (en) * | 2004-10-08 | 2011-01-18 | Suven Life Sciences Limited | Intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole |
| US20060079689A1 (en) * | 2004-10-12 | 2006-04-13 | Vladimir Naddaka | Processes for preparing and purifying carbostyril compounds such as aripiprazole and 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones |
| EP1812397A1 (en) * | 2004-11-18 | 2007-08-01 | Synthon B.V. | Process of making crystalline aripiprazole |
| CN1303068C (zh) * | 2005-01-11 | 2007-03-07 | 中国人民解放军第二军医大学 | 一种阿立哌唑的制备方法 |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JP2009508859A (ja) | 2005-09-15 | 2009-03-05 | エラン ファーマ インターナショナル リミテッド | ナノ粒子アリピプラゾール製剤 |
| EP1919453A2 (en) * | 2005-12-22 | 2008-05-14 | Teva Pharmaceutical Industries Ltd | Processes for reducing particle size of aripiprazole |
| US20070149782A1 (en) * | 2005-12-23 | 2007-06-28 | Michael Brand | Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole |
| US20070238876A1 (en) * | 2006-04-10 | 2007-10-11 | Neera Tewari | Process for the preparation of aripiprazole |
| EP2162135A4 (en) | 2007-05-21 | 2012-02-22 | Reviva Pharmaceuticals Inc | COMPOSITIONS, SYNTHESIS AND METHOD FOR THE APPLICATION OF ATTAINED CHINOLINONE-BASED ANTIPSYCHOTICS |
| WO2009154993A1 (en) | 2008-05-27 | 2009-12-23 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using piperazine based antipsychotic agents |
| CN101781246B (zh) * | 2009-01-15 | 2012-02-29 | 成都康弘药业集团股份有限公司 | 一种合成阿立哌唑的改进方法 |
| AU2010217772B2 (en) | 2009-02-26 | 2014-10-23 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of utilizing arylpiperazine derivatives |
| JOP20200109A1 (ar) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
| WO2016181406A1 (en) * | 2015-05-08 | 2016-11-17 | Davuluri Ramamohan Rao | Improved process for the preparation of aripiprazole with reduced particle size |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54130587A (en) * | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| DE3034237A1 (de) † | 1979-09-18 | 1981-04-16 | Otsuka Pharmaceutical Co. Ltd., Tokyo | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel |
| US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| JP2608788B2 (ja) * | 1988-10-31 | 1997-05-14 | 大塚製薬 株式会社 | 精神分裂病治療剤 |
| JP4060523B2 (ja) † | 1999-11-24 | 2008-03-12 | 大塚製薬株式会社 | カルボスチリル誘導体の製造法 |
| AR033485A1 (es) † | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
-
2003
- 2003-12-18 EP EP03780889A patent/EP1480953B2/en not_active Expired - Lifetime
- 2003-12-18 AT AT03780889T patent/ATE308524T1/de active
- 2003-12-18 DK DK03780889.6T patent/DK1480953T4/da active
- 2003-12-18 MX MXPA04002519A patent/MXPA04002519A/es active IP Right Grant
- 2003-12-18 TW TW092135997A patent/TWI258470B/zh not_active IP Right Cessation
- 2003-12-18 ES ES03780889T patent/ES2250919T5/es not_active Expired - Lifetime
- 2003-12-18 CA CA002458929A patent/CA2458929C/en not_active Expired - Fee Related
- 2003-12-18 WO PCT/JP2003/016256 patent/WO2004063162A1/en active IP Right Grant
- 2003-12-18 CA CA002676216A patent/CA2676216A1/en not_active Abandoned
- 2003-12-18 SI SI200330153T patent/SI1480953T2/sl unknown
- 2003-12-18 KR KR1020047003990A patent/KR100583667B1/ko active IP Right Grant
- 2003-12-18 AU AU2003288755A patent/AU2003288755C1/en not_active Ceased
- 2003-12-18 BR BRPI0305500-0A patent/BRPI0305500B1/pt unknown
- 2003-12-18 BR BR0305500-0A patent/BR0305500A/pt not_active IP Right Cessation
- 2003-12-18 DE DE60302139T patent/DE60302139T3/de not_active Expired - Lifetime
-
2004
- 2004-01-05 EG EG2004010004A patent/EG23557A/xx active
- 2004-01-05 AR ARP040100006A patent/AR042702A1/es not_active Application Discontinuation
- 2004-01-08 MY MYPI20040043A patent/MY129831A/en unknown
- 2004-01-08 US US10/752,490 patent/US6995264B2/en active Active
- 2004-01-09 CN CNB2004100020641A patent/CN1263742C/zh not_active Expired - Lifetime
-
2005
- 2005-07-11 HK HK05105804A patent/HK1073110A1/xx not_active IP Right Cessation
-
2011
- 2011-11-04 JP JP2011241871A patent/JP5797090B2/ja not_active Expired - Lifetime
-
2014
- 2014-03-06 JP JP2014043786A patent/JP2014148511A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2014027I2 (no) | aripiprazol | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK1480953T4 (da) | Fremgangsmåde til fremstilling af aripiprazol | |
| DK1611108T3 (da) | Fremgangsmåde til fremstilling af telmisartan | |
| DK1893586T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler | |
| CR8226A (es) | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos | |
| DK1720571T3 (da) | Fremgangsmåde til behandling af hæmolytisk sygdom | |
| DK2058243T3 (da) | Fremgangsmåde til fremstilling af drikke | |
| CL2008000069A1 (es) | Metodo de preparacion de compuestos derivados de 3,4-dihidroquinolina. | |
| DK1546122T3 (da) | Fremgangsmåde til fremstilling af valsartan | |
| DK2093217T3 (da) | Fremgangsmåde til fremstilling af form X af aripiprazol | |
| DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
| FI20055534A (fi) | Menetelmä verkkosuolen valmistamiseksi | |
| DK1805316T3 (da) | Fremgangsmåde til fremstilling af de enantiomere former af cis-3-hydroxycy- | |
| DK1678135T3 (da) | Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser | |
| DK1613599T3 (da) | Fremgangsmåde til fremstilling af 5-(halogenacetyl)-8-(substitueret oxy)-(1H)-quinolin-2-oner | |
| DK1572613T3 (da) | Fremgangsmåde til fremstilling af benzophenoner | |
| DK1575941T3 (da) | Fremgangsmåde til fremstilling af (S)-pantoprazol | |
| DK1912961T3 (da) | Fremgangsmåde til fremstilling af bepromolin | |
| DK1682541T3 (da) | Fremgangsmåde til fremstilling af tiotropiumsalte | |
| DK1931618T3 (da) | Fremgangsmåde til fremstilling af aniliner | |
| DK1727792T3 (da) | Fremgangsmåde til fremstilling af semicarbazoner | |
| DK1717311T3 (da) | Fremgangsmåde til fremstilling af lactoperoxidase | |
| DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater |